Prostate Cancer Trial, Recruiting NCT03908684 Sponsor: Sunnybrook Health Sciences Centre Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT03908684
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with prostate, rectal, or head and neck cancer (confirmed by a tissue or cell sample), have not yet received any first-line treatment, and are planned to receive radiation therapy.
  • Your cancer can be measured by ultrasound or MRI scan done within 28 days before starting treatment.
  • You are generally well enough to carry out daily activities with little or no limitation (as measured by a standard health scale called ECOG, scoring 0 or 1).
  • Your doctors expect you to live for at least 6 months.
  • Your blood, liver, and kidney function are within acceptable ranges, based on blood tests done within 7 days before starting treatment (confirm specific values with the trial site).
  • You are able to understand what the trial involves and are willing to sign a written consent form before any trial-related procedures begin.

Who may not be able to join:

  • You have had chemotherapy, radiation therapy, or major surgery within the last 4 weeks, or you are still recovering from side effects of earlier treatments.
  • You are currently taking part in another clinical trial involving an experimental treatment.
  • Your cancer has spread to the brain.
  • You have had a serious allergic reaction to a drug that is chemically similar to the one used in this trial.
  • You have a medical reason that makes radiation therapy unsafe for you, such as having previously had radiation to the same area, an active connective tissue disease, or a genetic condition that makes you especially sensitive to radiation.
  • You currently have a serious infection that requires antibiotic, antifungal, or antiviral medication.
  • You have an uncontrolled ongoing illness, such as an active infection, heart failure, unstable chest pain, or an irregular heartbeat.
  • You have a mental health condition or personal circumstances that would make it difficult to follow the trial's requirements.
  • You have an active seizure disorder, substance abuse issues, or other medical, psychological, or social conditions that could affect your participation or the reliability of results.
  • You have any other unstable condition that could put your safety at risk or affect your ability to follow the study plan.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gregory Czarnota, PhD, MD, Sunnybrook Health Sciences Centre

Phone: (416) 480-6128

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
17 December 2014
Est. completion
17 December 2025

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Radiation Treatment Response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov